Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.
Nat Commun
; 8: 15424, 2017 05 26.
Article
in En
| MEDLINE
| ID: mdl-28548080
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
DNA Modification Methylases
/
Drug Design
/
Histone-Lysine N-Methyltransferase
/
Hematologic Neoplasms
/
Enzyme Inhibitors
/
Antineoplastic Agents
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2017
Document type:
Article
Affiliation country:
España